Parallel Advisors, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,637
-66.3%
4350.0%0.00%
Q2 2023$10,805
+65.2%
4350.0%0.00%
Q1 2023$6,542
+27.1%
4350.0%0.00%
Q4 2022$5,146
+71.5%
4350.0%0.00%
Q3 2022$3,000
+50.0%
4350.0%0.00%
Q2 2022$2,000
-80.0%
435
-17.6%
0.00%
Q4 2021$10,000
+400.0%
528
+956.0%
0.00%
Q3 2021$2,0000.0%500.0%0.00%
Q2 2021$2,000
-33.3%
50
-21.9%
0.00%
Q1 2021$3,0000.0%640.0%0.00%
Q4 2020$3,000
+200.0%
64
+42.2%
0.00%
Q3 2020$1,000450.0%0.00%
Q2 2020$0450.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders